The first-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients with advanced tumors: a phase Ia/Ib study
首个靶向PD-1和PD-L1的双特异性抗体IBI318 (LY3434172)治疗晚期肿瘤患者的Ia/Ib期研究
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-024-01644-4
Ruan, Dan-Yun; Wei, Xiao-Li; Liu, Fu-Rong; Hu, Xi-Chun; Zhang, Jian; Ji, Dong-Mei; Huang, Ding-Zhi; Zhao, Yan-Qiu; Pan, Hong-Min; Liao, Wang-Jun; Yang, Kun-Yu; Xu, Nong; Lu, Xiao-Xiao; Chen, Yu-Ling; Zhang, Wen; Zhou, Hui; Zhao, Hong-Yun; Xu, Rui-Hua